150 related articles for article (PubMed ID: 37592220)
1. Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers.
Jacquet E; Chuffart F; Vitte AL; Nika E; Mousseau M; Khochbin S; Rousseaux S; Bourova-Flin E
BMC Genomics; 2023 Aug; 24(1):463. PubMed ID: 37592220
[TBL] [Abstract][Full Text] [Related]
2. A cell-to-patient machine learning transfer approach uncovers novel basal-like breast cancer prognostic markers amongst alternative splice variants.
Villemin JP; Lorenzi C; Cabrillac MS; Oldfield A; Ritchie W; Luco RF
BMC Biol; 2021 Apr; 19(1):70. PubMed ID: 33845831
[TBL] [Abstract][Full Text] [Related]
3. NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.
Mendiburu-Eliçabe M; García-Sancha N; Corchado-Cobos R; Martínez-López A; Chang H; Hua Mao J; Blanco-Gómez A; García-Casas A; Castellanos-Martín A; Salvador N; Jiménez-Navas A; Pérez-Baena MJ; Sánchez-Martín MA; Abad-Hernández MDM; Carmen SD; Claros-Ampuero J; Cruz-Hernández JJ; Rodríguez-Sánchez CA; García-Cenador MB; García-Criado FJ; Vicente RS; Castillo-Lluva S; Pérez-Losada J
Clin Transl Med; 2024 Feb; 14(2):e1554. PubMed ID: 38344872
[TBL] [Abstract][Full Text] [Related]
4. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
[TBL] [Abstract][Full Text] [Related]
6. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
[TBL] [Abstract][Full Text] [Related]
8. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
9. Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.
Pece S; Disalvatore D; Tosoni D; Vecchi M; Confalonieri S; Bertalot G; Viale G; Colleoni M; Veronesi P; Galimberti V; Di Fiore PP
EBioMedicine; 2019 Apr; 42():352-362. PubMed ID: 30846393
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Roll JD; Rivenbark AG; Sandhu R; Parker JS; Jones WD; Carey LA; Livasy CA; Coleman WB
Exp Mol Pathol; 2013 Dec; 95(3):276-87. PubMed ID: 24045095
[TBL] [Abstract][Full Text] [Related]
11. A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer.
Chiodoni C; Sangaletti S; Lecchi M; Ciniselli CM; Cancila V; Tripodi I; Ratti C; Talarico G; Brich S; De Cecco L; Baili P; Truffi M; Sottotetti F; Piccotti F; Tripodo C; Pruneri G; Triulzi T; Corsi F; Cappelletti V; Di Cosimo S; Verderio P; Colombo MP
ESMO Open; 2023 Aug; 8(4):101590. PubMed ID: 37393630
[TBL] [Abstract][Full Text] [Related]
12. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease.
Gong DH; Fan L; Chen HY; Ding KF; Yu KD
Oncotarget; 2016 May; 7(19):28570-8. PubMed ID: 27086913
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
15. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.
Yau C; Esserman L; Moore DH; Waldman F; Sninsky J; Benz CC
Breast Cancer Res; 2010; 12(5):R85. PubMed ID: 20946665
[TBL] [Abstract][Full Text] [Related]
16. Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse.
Gu Y; Chow MJ; Kapoor A; Lin X; Mei W; Tang D
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578925
[TBL] [Abstract][Full Text] [Related]
17. Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.
Li CI; Zhang Y; Cieślik M; Wu YM; Xiao L; Cobain E; Tang MC; Cao X; Porter P; Guenthoer J; Robinson DR; Chinnaiyan AM
Clin Cancer Res; 2021 Jun; 27(11):3079-3093. PubMed ID: 33753452
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Aiderus A; Black MA; Dunbier AK
BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
[TBL] [Abstract][Full Text] [Related]
19. A multiple breast cancer stem cell model to predict recurrence of T
Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
[TBL] [Abstract][Full Text] [Related]
20. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
